Dividend YouTube sentiment
- Bullish
- 2
- Bearish
- 0
- Neutral
- 2
Across 4 videos from 4 dividend investing channels in the last 90 days. Each mention scores +1 bullish, −1 bearish, −0.5 for a flagged risk, 0 neutral; the average maps onto 0–100, where 50 is balanced. This measures what creators said, not how ABBV is likely to perform, and is not a recommendation. How this index works
What dividend YouTubers said about ABBV recently
AbbVie Inc. (ABBV) was discussed in 4 videos from 4 dividend investing channels in the last 90 days, including Peter Pru, GenExDividendInvestor, Income Architect and John's Money Adventures. Each entry below links straight to the moment ABBV comes up, so you can hear the reasoning rather than take our summary for it.
Peter Pru · Aug 17, 2026 · 535 views
“Top holding in SCHD/DGRO; suggested for covered call strategies to generate premium.”
GenExDividendInvestor · Aug 15, 2026 · 4,199 views
“Example of individual dividend stock that feels good to own directly but may underperform broad market indexing.”
Income Architect · Aug 14, 2026 · 4,964 views
“Portfolio holding; selected for being top-tier in segment with visionary leadership and strong shareholder yield.”
- This Is The LOWEST Amount You Need to Let Dividend Snowball WorkBuying / holding
John's Money Adventures · Aug 9, 2026 · 11,545 views
“Raised dividends every year since 2013 spinoff despite Humira patent loss; 2.67% yield, 11.89% dividend growth, 14.94% appreciation.”
Creator views are their own and are not recommendations by REWD, nor a signal that we agree. We index what was said so you can check it against ABBV’s actual payout ratio and dividend history. See the full dividend YouTube index for what creators are discussing across the whole market.
This tool is for educational and informational purposes only and does not constitute investment, financial, tax, or legal advice. Consult a licensed professional before making investment decisions.
Past performance does not guarantee future results. All projections are hypothetical estimates based on user-provided inputs and may differ materially from actual outcomes.
By using this tool you agree to our Terms of Service and Privacy Policy.